Brigit Biofarmaka Teknologi Tbk. vs Phapros Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp236 (market cap 164.65B, 62.5K 24h volume), while Phapros Tbk. trades at Rp300 (market cap 221.76B, 7.89M 24h volume). The key difference: Phapros Tbk. is the larger of the two by market cap, and Phapros Tbk. is more actively traded (7.89M versus 62.5K). Which is the better fit depends on your goals.
| OBAT | PEHA | |
|---|---|---|
Market Cap | 164.65B | 221.76B |
Volume | 62.5K | 7.89M |
Lot | 625 | 78.91K |
Turnover | 15.03M | 2.48B |
Average Price | 240.55 | 314.91 |
Value | 15.03M | 2.48B |
Indicative Equilibrium Price | 238 | 300 |
Indicative Equilibrium Volume | 100 | 1.06K |
Trailing returns across standard periods
Latest headlines on both assets
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →PT Phapros Tbk was established under the name of N.V. Pharmaceutical Processing Industries, in short N.V. Phapros, based on Notarial Deed No 54 of Tan A Sioe dated 21 June 1954, which later became PT Pharmaceutical Processing Industries, in short PT Phapros based on Notarial Deed No.43 of E. Pondaag, replacing R.M. Soerojo, dated 5 September 1995, which finally became PT Phapros based on Notarial Deed No. 48 of Prof. Dr. Liliana Tedjosaputro, S.H., M.H., MM., dated 12 April 2006. The Company’s immediate and ultimate parent entity is PT Rajawali Nusantara Indonesia, incorporatedand domiciled in Indonesia.
Read more on PEHA →